Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 6  /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that management will present a corporate overview at the upcoming Bear Stearns 20th Annual Healthcare Conference on Tuesday, September 11th at 2:00 p.m. (EDT) and at the Maxim Group 1st Annual Growth Conference on Thursday, September 20th at 3:30 p.m. (EDT), both of which are being held in New York.

The live and archived webcasts of the presentations can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com/.  Please log in approximately 5-10 minutes before the events to ensure a timely connection.  The archived replays will be available on the Idenix website for two weeks following the conferences.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV).  For further information about Idenix, please refer to http://www.idenix.com/.

  Idenix Pharmaceuticals' Contacts:
  Media: Teri Dahlman [phone]
  Investors: Amy Sullivan [phone]


DATASOURCE: Idenix Pharmaceuticals, Inc.



CONTACT:  Media, Teri Dahlman, [phone], or Investors, Amy

Sullivan, [phone], both of Idenix Pharmaceuticals



Web site:  http://www.idenix.com/ 

Copyright